BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 38601205)

  • 1. Factors Affecting Survival Outcomes in Neuroendocrine Tumor of the Appendix over the Past Two Decades.
    Nagesh VK; Aguilar IK; Elias D; Mansour C; Tran HH; Bhuju R; Sethi T; Sanjeeva PRP; Rivas MG; Martinez E; Auda A; Ahmed N; Philip S; Weissman S; Sotiriadis J; Bangolo A
    Diseases; 2024 May; 12(5):. PubMed ID: 38785751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing surgical and endoscopic resection approaches for colorectal neuroendocrine tumors within the diameter range of 10-20mm: an inverse probability weighting analysis based on the SEER database.
    Xu J; Liang R; Cai Q; Liu Y; Ge X; Lai B; Mao S; Cao J; Wang J
    Front Endocrinol (Lausanne); 2024; 15():1378968. PubMed ID: 38601205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of prognosis after partial and total surgical resection for parathyroid carcinoma: an inverse probability of treatment weighting analysis of the SEER database.
    Jin S; Cho WC; Yang J; Xia K; Zhou C
    Front Endocrinol (Lausanne); 2023; 14():1167508. PubMed ID: 37916151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal Cut-Off Values of the Positive Lymph Node Ratio and the Number of Removed Nodes for Patients Receiving Resection of Bronchopulmonary Carcinoids: A Propensity Score-Weighted Analysis of the SEER Database.
    Chen Q; Li M; Wang P; Chen J; Zhao H; Zhao J
    Front Oncol; 2021; 11():696732. PubMed ID: 34367980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary tumor resection and lymph node dissection improve survival in
    Wu C; Zhang X; Wang T; Zhou H; Guo C; Chen Y; Zhao D
    Transl Cancer Res; 2020 May; 9(5):3312-3323. PubMed ID: 35117698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
    Mao R; Zhao H; Li K; Luo S; Turner M; Cai JQ; Blazer D
    Ann Surg Oncol; 2019 Sep; 26(9):2722-2729. PubMed ID: 31209670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine Carcinoma.
    Li Z; Ren H; Wang T; Zhang X; Zhao L; Sun C; Niu P; Guo C; Chen Y; Zhao D
    Front Oncol; 2022; 12():930491. PubMed ID: 35912176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours.
    Rinke A; Ambrosini V; Dromain C; Garcia-Carbonero R; Haji A; Koumarianou A; van Dijkum EN; O'Toole D; Rindi G; Scoazec JY; Ramage J
    J Neuroendocrinol; 2023 Jun; 35(6):e13309. PubMed ID: 37345509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEN Gain or NEN Loss: Endoscopic Resection for Rectal Neuroendocrine Neoplasms < 15 mm.
    Rossi RE; Massironi S
    Dig Dis Sci; 2023 Jul; 68(7):2793-2795. PubMed ID: 37213004
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of Endoscopic Resection for Rectal Neuroendocrine Tumors Smaller than 15 mm.
    Hamada Y; Tanaka K; Mukai K; Baba Y; Kobayashi M; Tominaga S; Kawabata H; Sawai S; Kaneko M; Sugimoto S; Inoue H; Mimuro M; Tamaru S; Nakagawa H
    Dig Dis Sci; 2023 Jul; 68(7):3148-3157. PubMed ID: 37024740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance.
    Gallo C; Rossi RE; Cavalcoli F; Barbaro F; Boškoski I; Invernizzi P; Massironi S
    World J Gastroenterol; 2022 Mar; 28(11):1123-1138. PubMed ID: 35431507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study.
    Ricci AD; Pusceddu S; Panzuto F; Gelsomino F; Massironi S; De Angelis CG; Modica R; Ricco G; Torchio M; Rinzivillo M; Prinzi N; Rizzi F; Lamberti G; Campana D
    J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "The past is a different country, they do things differently there": using the SEER data-base to assess prognosis in neuroendocrine tumours.
    Alexandraki KI; Zatelli MC; Grossman AB
    Endocrine; 2022 Mar; 75(3):725-727. PubMed ID: 35037238
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.